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Abstract: A new series of structurally simple compounds containing thiourea groups have been shown by a combination of ion-
selective electrode and 13C NMR techniques to be potent chloride-bicarbonate exchange agents that function at low 
concentration in POPC and POPC/cholesterol membranes. 10 
Introduction 
Anion transport1 is key to many biological processes.  Mis-
regulation of the transport of chloride across cell membranes 
can lead to diseases such as cystic fibrosis (caused by the 
reduction or absence of conductance across epithelial cell 15 
membranes as a consequence of a mutation in the CFTR anion 
channel), Bartter’s syndrome and Dent’s disease (resulting 
from mutations in genes which encode for chloride or salt 
transport channels in renal cells).2  Similarly misregulation of 
bicarbonate transport has also been implicated in cystic 20 
fibrosis3 and other diseases.4  Consequently a number of 
groups have developed synthetic anion channels and discrete 
molecular carriers to transport chloride across lipid bilayer 
membranes.5  Our interests have recently focused on the 
development of small molecules capable of 25 
chloride/bicarbonate antiport.6,7  
 Ureas and thioureas form stable complexes with oxo-anions 
and have been employed in a wide variety of receptors for 
these species.8  We have recently shown that tris(2-
aminoethyl)amine (tren) based tris-thioureas 1 and 2 function 30 
as potent chloride/bicarbonate antiport agents in POPC 
liposomes.9  Tren-based tris-amides were first shown to bind 
anions such as chloride by Reinhoudt and co-workers,10 whilst 
tren-based ureas have been shown by Custelcean and co-
workers11 and Ghosh and co-workers12 and others to be 35 
effective hosts for oxo-anions whilst the transport properties 
of tren-based anion receptors have been investigated by DK. 
Smith and co-workers in U-tube experiments,13 J.T. Davis and 
co-workers in lipid bilayers 14  and their flippase activity in 
lipid bilayers by B.D. Smith and co-workers.15  In our studies 40 
we found that thioureas were significantly more effective 
transporters than analogous ureas. In previous work A.P. 
Davis and co-workers have shown that a simple 4-
nitrophenylurea when pre-incorporated into a lipid bilayer 
functions as a chloride transporter at concentrations of 45 
transporter/lipid of 1:150.16  B.D. Smith and co-workers have 
incorporated urea groups into phospholipids and shown that 
these compounds function as anion transporters by a relay 
mechanism in which one functionalised lipid ‘hands’ the 
anion over to another in the opposite leaflet.17 Hence we 50 
decided to study a series of very simple thiourea based 
compounds and compare their anion transport activity to 
analogous ureas, amides and thioamides.  The results show 
that very simple compounds containing thiourea groups, 
without pre-incorporation into a lipid bilayer, function as 55 
potent chloride/bicarbonate antiport agents at relatively low 
concentrations.  
 
Results and Discussion 
We decided to study a series of ureas and thioureas that had 60 
one common side chain and one substituent that would vary 
across the series.  We chose the iso-pentyl side chain as the 
common substituent in these compounds as our previous 
studies had shown that 4,6-dihydroxyisophthalamides with 
this substituent were particularly effective membrane 65 
transporters.6  Each compound was then prepared as the urea 
and thio urea derivative with either n-butyl-, phenyl- or 7-
indolyl substituents to study the effects of changing the 
electronics of this substituent and also the effect of adding an 
additional hydrogen bond donor group.  Indoles have recently 70 
been employed in a variety of effective anion receptors and 
anion-templated foldamers.18 Compounds 3 – 6 were prepared 
by reaction of either phenyl or butyl isocyantate or 
isothiocyanate in dichloromethane or chloroform with iso-
pentylamine affording the compounds in 49, 49, 72 and 48% 75 
respective yields.  Compound 7 was prepared by reduction of 
7-nitroindole to the amine and then reaction with CDI to 
afford an activated intermediate which was then coupled to 
iso-pentylamine affording the product in 44% overall yield.  
Compound 8 was prepared by reaction of 7-aminoindole with 80 
thiophosgene to afford the isothiocyanate that was then 
coupled with iso-pentylamine to afford the product in 24% 
overall yield. 
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Proton NMR titrations were used to determine the stability 
constants of compounds 3-8 with chloride and nitrate (added 
as tetrabutylammonium salts) and bicarbonate (added as the 5 
tetraethylammonium salt) in DMSO-d6/0.5% water solution 
using the WinEQNMR computer program.19  The results 
(shown in Table 1) show that the compounds do not 
detectably interact with nitrate in this solvent mixture but do 
bind chloride with the indole-based compounds showing the 10 
highest affinity for this anion (and in particular the urea 
derivative).  Similarly bicarbonate is bound most strongly by 
the indole urea followed by the indolylthiourea. 
 In order to study the chloride transport properties of 
compounds 3-8 we prepared a series of unilamellar 1-15 
palmitoyl-2-oleoylphophatidylcholine (POPC) vesicles loaded 
with sodium chloride (489 mM) and suspended them in an 
external NaNO3  (489 mM) solution. A sample of the receptor 
(2% molar carrier to lipid) was added as a DMSO solution and 
the resultant chloride efflux monitored using a chloride 20 
selective electrode.20  After 300 s, the vesicles were lysed by 
addition of detergent and the final reading of the electrode 
was used to calibrate 100% release of chloride.  The results 
show that the compounds containing urea groups show no 
significant release of chloride under these conditions.  25 
Compound 6 the phenylthiourea shows moderate activity 
whilst the butylthiourea and the indolylthiourea both 
efficiently release chloride from the vesicles.  The EC50 values 
for the compounds are shown in Table 2. Transport 
experiments were repeated in vesicles composed of 30 
POPC/cholesterol 70:30 and showed a slightly reduced rate of 
transport for the thiourea compounds – evidence that these 
species are functioning as carriers rather than forming 
channels (ESI Figures S29-31).  It is notable that the 
performance of the thiourea compounds in the 35 
POPC/cholesterol membrane is still excellent as this mixture 
more closely mimics biological cell membranes. 
 
Table 1. Stability constants (Ka/M-1) for compounds 3-8 with anionic 
guests in DMSO-d6/0.5% water solution at 298K. All errors are < 15%. 40 
Stability constants were calculated following the shift of the iso-pentyl 
NH group. 
Compounds NO3-[a] Cl-[a] HCO3-[b] 
3 [c] < 10 18 
4 [c] 10 58 
5 [c] 21  135  
6 [c] 22  343[d]  
7 [c] 96  1170  
8 [c] 28 516  
[a] Added as the tetrabutylammonium salt. [b] Added as the 
tetraethylammonium salt. [c] No interaction observed. [d] NH resonances 
broaden considerably during this titration 45 
 
Figure 1 Chloride efflux promoted by 0.02 molar equiv of receptors 3-8 
from unilamellar POPC vesicles loaded with 489 mM NaCl buffered to 
pH 7.2 with sodium phosphate salts. The vesicles were dispersed in 489 
mM NaNO3 buffered to pH 7.2 with 5 mM sodium phosphate salts. At the 50 
end of the experiment, detergent was added to lyse the vesicles and 
calibrate the ISE to 100% chloride release. Each point represents the 
average of three trials. 
 
 We had previously shown that tren-based tris thioureas 1 55 
and 2 were potent chloride/bicarbonate antiporters in POPC 
vesicles. We wished to compare the bicarbonate transport 
ability of the simpler mono-ureas and mono-thioureas 3-8 
with the tren-based tris- ureas 1-2.  Vesicles containing NaCl 
were prepared and suspended in a solution of Na2SO4 and a 60 
sample of receptor in DMSO solution was added to this 
suspension (2% molar carrier to lipid). The negligible release 
of chloride under these conditions rules out that these 
compounds function as NaCl or HCl co-transporters to a 
significant degree. A pulse of bicarbonate was added after 120 65 
s to the external solution.  If the compounds function as Cl-
/HCO3- antiporters then efflux of chloride should be observed 
upon addition of the bicarbonate to the external solution.  
Once again no activity was observed with the urea compounds 
under these conditions (Figure 2).  However, both the 70 
butylthiourea 4 and phenylthiourea 6 release chloride from the 
vesicles under these conditions with the butylthiourea 
derivative 4 showing slightly faster release of chloride – 
however the difference in activity of these compounds is 
significantly less than was observed in the Cl-/NO3- antiport 75 
experiments.  More active are the tris-thioureas 1 and 2 whilst 
the most active chloride/bicarbonate antiporter is the 
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indolylthiourea 8.  It should be noted that in the case of 
compounds 1 and 2 there are three thiourea groups per 
receptor and hence the concentration of thiourea groups in the 
experiments with 1 and 2 are three times higher than with 
compound 8.  5 
 
 
Figure 2 Chloride efflux promoted by 0.02 molar equiv of receptors 1-8 
from unilamellar POPC vesicles loaded with 489 mM NaCl buffered to 
pH 7.2 with 20 mM sodium phosphate salts upon addition of a NaHCO3 10 
pulse to make the extravesicular bicarbonate concentration 40 mM. The 
vesicles were dispersed in 167 mM Na2SO4 buffered at pH 7.2 with 20 
mM sodium phosphate salts. At the end of the experiment, detergent was 
added to lyse the vesicles and calibrate the ISE to 100% chloride release. 
Each point represents the average of 3 trials.  15 
 
 
The data shown in Fig. 2 provided compelling, yet indirect, 
evidence that the thioureas 4, 6 and 8 are able to promote the 
transport of bicarbonate across phospholipid membranes. We 20 
turned to 13C NMR spectroscopy to gain direct evidence that 
these thioureas 4, 6 and 8 facilitate transmembrane HCO3-/Cl- 
exchange (see Fig. 3 and ESI).6 In these NMR experiments we 
monitored bicarbonate efflux from vesicles loaded with 
H13CO3- after the addition of compounds 3-8. EYPC vesicles 25 
filled with H13CO3- and suspended in Na2SO4 solution were 
aged overnight at 4 ºC. Two 13C NMR signals separated by 
about 1 ppm  (δ ~161 and ~160 ppm) were observed, 
corresponding to signals for intravesicular and extravesicular 
H13CO3- respectively (Fig. 3). No leakage of H13CO3- from 30 
these vesicles occurred after addition of 50 mM NaCl. A 
DMSO solution of the transporters was then added to give 
ligand-to-lipid ratios of 0.04 mol % for 1-8 (see Fig. S91 in 
the Supporting Information) and 13C NMR spectra were 
recorded 5 min after addition of compounds 1-8.  As an 35 
example of the activity of the thioureas, as compared to the 
urea analogs see Fig. 3. Thus, thiourea 8 promoted complete 
Cl-/H13CO3- exchange in 5 min, as confirmed by the 
observation of only the NMR signal for extravesicular 
H13CO3- (Figure 3). Addition of Mn2+ broadened this sharp 40 
H13CO3- signal at δ 160 ppm into the baseline, confirming that 
all of the intravesicular H13CO3- had been exchanged into the 
extravesicular solution in the 5 min period. In marked 
contrast, after addition of the urea analogue 7 the separate 
signals for intravesicular and extravesicular H13CO3-  45 
remained relatively unchanged. Addition of Mn2+ to this 
control sample simply erased the smaller extravesicular 
H13CO3- signal, whereas the major intravesicular H13CO3- 
signal remained intact since the paramagnetic Mn2+ cannot 
cross the phospholipid membrane. This 13C NMR data in Fig. 50 
3 was consistent with the ISE data in Fig. 2, which showed 
that thiourea 8 is a relatively potent anion transporter, whereas 
the urea analogue 7 is essentially inactive as an anion 
transporter. 
 55 
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 65 
 
 
 
 
 70 
Figure 3 13C NMR evidence for H13CO3-/Cl- exchange promoted by 0.04 
molar equiv of thiourea transporter 8.  a) before and b) after addition of a 
50 mM NaCl pulse to EYPC vesicles containing 100 mM NaH13CO3 
buffered to pH 7.4 with 20 mM HEPES, dispersed in 75 mM Na2SO4 
buffered to pH 7.4 with 20 mM HEPES; c) 5 min after addition of a 75 
DMSO blank, urea 7, or thiourea 8; d) following addition of 0.5 mM 
MnCl2, a paramagnetic line broadening agent that only affects 
extravesicular bicarbonate. 
 
The EC50 values at 270 s were calculated for the thiourea 80 
compounds for chloride release in both the nitrate and 
bicarbonate antiport systems using Hill analysis (see 
supplementary information for details).  The results are shown 
in Table 2 together with the initial rates of chloride release for 
these compounds and are presented with parameters used in 85 
the absorption, distribution, metabolism, excretion and 
toxicity (ADMET) assessment in drug discovery21 specifically 
the calculated Ghose-Crippen log P values22 for compounds 3 
– 8 and the polar surface area (PSA) of the compounds both 
calculated using the Spartan ’08 computer program.23  We 90 
reasoned that the parameters that need to be optimised for a 
compound to be ‘drug-like’24 may correspond to those of an 
efficient carrier in that the compound would optimally possess 
both hydrophobic and hydrophilic properties to be capable of 
extracting an anion from aqueous solution and transporting it 95 
across a lipid bilayer. The results show that the thioureas have 
a higher clog P than the urea analogues and a lower polar 
surface area.  The indolylurea and thiourea have the highest 
stability constants for bicarbonate from the members of this 
series and we hypothesise that the activity of the 100 
indolylthiourea compound 8 is in part due to a balance of 
affinity resulting from the geometry and number of hydrogen 
bond donors in the binding site, higher log P and moderate 
PSA from amongst this series of compounds.  The low EC50 
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values for compound 8 promoted us to study the chloride 
transport properties of this receptor at a range of different 
transporter:lipid loadings in a Cl-/NO3- system.  The results 
show chloride transport activity down to a ratio of 1:25000 
transporter:lipid – a remarkable result for such as simple 5 
compound not pre-incorporated into the lipid bilayer 
membrane (Figure 4). 
Table 2 EC50 values and initial rate of chloride release (% chloride efflux 
per second) for compounds 4, 6 and 8 for release of chloride in 
chloride/nitrate and chloride/bicarbonate systems at 270s. Calculated log 10 
P and TPSA (Å2) are also presented for compounds 3 – 8. 
Compo
unds 
EC50 at 
270s 
(Cl-
/NO3-) 
Initial 
rate of 
chloride 
release 
(Cl-/NO3-
) % Cl- 
efflux/s 
at 2% 
carrier 
loading 
EC50 at 
270s (Cl-
/HCO3-) 
Initial 
rate of 
chloride 
release 
(Cl-
/HCO3-) 
% Cl- 
efflux/s 
at 2% 
carrier 
loading 
clog
P[a] 
PSA 
(Å2)[
b] 
3 - - - - 1.99 37.0 
4 0.1491
% 
0.431 0.6049% 0.227 3.14 22.2 
5 - - - - 2.42 34.8 
6 3.0667
% 
0.074 2.7848% 0.188 3.57 21.5 
7 - - - - 2.02 44.6-
47.7 
8 0.02663
% 
0.614 0.0405% 0.386 3.16 31.3-
35.5 
[a] clog P calculated using Spartan ’08 for Macintosh (Ghose-Crippen 
model).  [b] Polar surface area (PSA) calculated using Spartan ’08 for 
Macintosh. The receptors were minimised using AM1 semi-empirical 
methods with the two urea or thiourea NH groups parallel and the PSA 15 
and log P values calculated.  In the case of the case of the indole 
containing species two conformations were minimised – one with the 
indole NH forming a convergent array with the urea NH groups and the 
other with the indole NH oriented towards the urea or thiourea O or S 
atom (hence a range of values for PSA are given). 20 
 
Figure 4  Chloride efflux promoted by 0.00004, 0.0001, and 0.0004 
molar equiv of receptor 8 from unilamellar POPC vesicles loaded with 
489 mM NaCl buffered to pH 7.2 with sodium phosphate salts. The 
vesicles were dispersed in 489 mM NaNO3 buffered to pH 7.2 with 5 mM 25 
sodium phosphate salts. At the end of the experiment, detergent was 
added to lyse the vesicles and calibrate the ISE to 100% chloride release. 
Each point represents the average of three trials. 
 
 We also prepared a series of amides and thioamides with 30 
analogous structures to the series of ureas and thioureas.  The 
transport ability of these compounds  (9-14) was studied using 
under the same conditions as the ureas and thioureas for 
chloride/nitrate antiport.  The results (Figure 5) show a much 
diminished chloride transport ability for thioamides 10 and 14 35 
as compared to thioureas 4 and 8. 
 
 
Figure 5 Chloride efflux promoted by 0.02 molar equiv of receptors 9-14 
from unilamellar POPC vesicles loaded with 489 mM NaCl buffered to 40 
pH 7.2 with sodium phosphate salts. The vesicles were dispersed in 489 
mM NaNO3 buffered to pH 7.2 with 5 mM sodium phosphate salts. At the 
end of the experiment, detergent was added to lyse the vesicles and 
calibrate the ISE to 100% chloride release. Each point represents the 
average of three trials. 45 
Conclusion 
A series of simple ureas and thioureas have been synthesised 
and their anion transport properties studied by a combination 
of ion-selective electrode and 13C NMR techniques.  The 
results show that very simple thiourea compounds such as 4, 6 50 
and 8 are capable of chloride/bicarbonate antiport with 
compounds 4 and 8 possessing the highest transport 
efficiency. Analogous amides and thioamides have greatly 
diminished anion transport abilities.  The ‘champion’ of this 
series, compound 8, combines a higher clogP and lower polar 55 
surface area than its urea analogue, which is inactive as a 
chloride/bicarbonate antiport agent, with a convergent array of 
three hydrogen bond donors.  This results in remarkably 
potent anion transport properties for such as simple 
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compound.  The goal of using small molecules as treatments 
for diseases caused by misregulation of chloride transport, 
such as cystic fibrosis, will be brought closer when 
compounds designed as membrane transporters have 
optimised ADMET properties.  Conversely by optimising 5 
ADMET properties we may at the same time improve the 
anion transport properties of these species (with the caveat 
that unlike small molecule drugs, we wish the compound to 
remain in the membrane and not diffuse through it). 
 10 
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